Astex Pharmaceuticals, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly To Discover, Develop Oligonucleo

Mosaic Therapeutics is in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals in a deal that will significantly accelerate Mosaic’s development path, with its first clinical c

The pharmaceutical, biotech and other allied industries came together in London on 4 December to celebrate another year of exceptional achievement at the 20th Annual Scrip Awards at the Raffles hotel

The US Food and Drug Administration beats the European Medicines Agency to approval of novel agents across the board, but the imbalance is even more stark in oncology, the largest therapy area, a Pin